CellBridge Bio
赛桥生物
CellBridge Bio
Biotech/Healthcare
Founded in February 2020, CytivaBio focuses on original innovation and domestic development of critical upstream manufacturing technologies and integrated core equipment for the cell and gene therapy (CGT) industry. The company enables fully closed, automated, digital, and flexible CGT…
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.